SAM
VRX

Shikiar Asset Management’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Shikiar Asset Management’s Portfolio VRX Stock Details VRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-35,080
Closed -$6.97M – 114
2015
Q1 		$6.97M Buy
+35,080
New +$6.97M 3.03% 13

Other funds holding VRX

CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Shikiar Asset Management's VRX Position: Q2 2015 in Review

Shikiar Asset Management sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q2 2015, closing a stake of 35,080 shares — an estimated $6.97M sold.

Shikiar Asset Management first reported a position in VRX in Q1 2015 and held it in 1 quarter. The position peaked at $6.97M in Q1 2015. 1 fund tracked by Wall St. Rank holds VRX as of Q2 2015.

  • Shikiar Asset Management reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q2 2015 after selling out during the quarter.
  • Shikiar Asset Management sold 35,080 VALEANT PHARMACEUTICALS INTL shares in Q2 2015, an estimated $6.97M.
  • Shikiar Asset Management first reported a position in VALEANT PHARMACEUTICALS INTL in Q1 2015 and held it in 1 quarter.
  • Shikiar Asset Management's VALEANT PHARMACEUTICALS INTL position peaked at $6.97M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q2 2015.

Based on Shikiar Asset Management's 13F filing for Q2 2015, filed 28 Jul 2015.